- Supplements Facts
- Scientific References
- Client Reviews
Support Liver Health and Help Detoxify Your Body
TrueMilkThistle™ is part of NatureCity’s “3-2-1” Detox” rotation designed to help support liver health (TrueGreenTea with SOD™ and TrueALA are the other two products).
This formula includes a high quality milk thistle, containing 80% silymarin, the key active biological compound in milk thistle.
While the liver helps protect you from toxins, milk thistle helps protect the liver from toxins. Milk thistle also promotes new liver cell production.
TrueMilkThistle™ also contains N-acetyl cysteine (NAC), which is a version of the sulfur containing amino acid cysteine. NAC helps replenish glutathione and supports the detoxifying efforts of your liver. NAC also helps regulate inflammation and boost immune system function. Its benefits have been demonstrated in over 30 placebo controlled clinical studies.
Complementing this formula is the SelenoExcell® brand of selenium. It is the “gold standard” in selenium ingredients and fermented from high selenium yeast. Besides being an important antioxidant, selenium is used by your body as a catalyst to produce other antioxidants and enzymes crucial for detoxing and overall health.
When it comes to selenium supplements, the type used matters because there are actually many forms of active selenium molecules used by the body. And SelenoExcell® contains multiple organic selenium compounds, whereas traditional selenium contains only one. This makes SelenoExcell® much more potent and beneficial as an antioxidant.
This is also believed to be why SelenoExcell® has been shown in certain clinical trials to produce results when other forms of selenium don’t.
Euromed: Supplier of the Clinically Researched Milk Thistle
Milk thistle is one of the oldest and most extensively studied plants for liver health.
Most of this research has been done using milk thistle extracts from a company based outside of Barcelona, Spain named Euromed.
Over the last 40 years, Euromed milk thistle has been the subject of approximately 50 research studies. This research has been conducted on a wide range of people with virtually no unwanted side effects reported (it may have a mild laxative effect in some individuals).
Because of their long record of quality and efficacy, we chose to feature Euromed milk thistle in our TrueMilkThistle™ product.
Euromed milk thistle is standardized to contain a minimum 80% silymarin - a mixture of isomers that provide the beneficial health properties from milk thistle.
The raw material to make this ingredient is sourced in Spain and Central Europe using strict selection guidelines. Extraction and final testing is done in Euromed’s Spanish facility in Mollet del Valles (outside of Barcelona).
This facility obtained NSF International certification for utilizing Good Manufacturing Practices (GMPs) and Euromed was also awarded "Green" 14001 Certification from ISO, the International Standardization Organization.
This award demonstrates Euromed's dedication to establishing and maintaining sustainable and environmentally friendly manufacturing processes.
SelenoExcell®: Replicating How Selenium is Found in Food
Selenium is a crucial nutrient for the body. One of its most important functions is helping to produce antioxidant enzymes such as glutathione peroxidase.
As a part of our natural enzyme system, selenium works to stop free radical production at the cellular level. Many other antioxidants deal with free radicals once they are active - primary antioxidants like selenium prevent free radicals from being produced at the outset.
Most supplements are made with one form of selenium such as selenomethionine. However, selenium in food is actually a cluster of different selenium molecules - which is what your body needs.
And providing multiple forms of selenium is exactly what the yeast derived SelenoExcell® uniquely provides. For example, SelenoExcell® naturally includes selenomethionine, selenocysteine and methylselenocysteine and other forms of selenium.
SelenoExcell® originates from a non-pathogenic, non-GMO Saccharomyces cerevisiae yeast strain. It creates a product that is the closest to food forms of selenium, like what is found in Brazil nuts, eggs, peas, poultry, and meats.
The yeast fermentation process replicates the natural course in which plants absorb and transform minerals from the soil into a more bioavailable form that improves the nutrition and health properties of selenium.
This particular yeast used to make SelenoExcell® is able to accumulate and incorporate selenium into the protein structure. This enhances its antioxidant properties and ability to fight oxidative stress in the body.
What’s more, the selenium in SelenoExcell® is what researchers call organic, meaning it is attached to several amino acids. This factor may make it more bioavailable than other forms found in supplements.
Dietary Supplement / 60 Veggie Capsules
Serving Size: 2 Capsules
Servings per Container: 30
|Amount Per Serving||% Daily Value|
|Selenium (from high-selenium yeast) (SelenoExcell®)||100 mcg||182%|
|Milk thistle seed extract (80% silymarin, calculated as silibinin)||250 mg||*|
|N-Acetyl cysteine (NAC)||250 mg||*|
* Daily value not established.
Other ingredients: Rice flour, hypromellose, stearic acid and rice hull concentrate.
SelenoExcell® is a registered trademark of Cypress Systems, Inc.
Suggested Use: Take two (2) capsules daily with water or as directed by your health care practitioner.
TrueMilkThistle™ with NAC and selenium helps promote healthy antioxidant levels and supports liver health.†
- Keep out of reach of children
- Do not use if seal is broken or missing
- Store in a cool dry place
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Gluten Free
- BPA Free
- Assembled in the USA
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
Milk Thistle (Silymarin)
Surai PF “Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives.” Antioxidants (Basel). 2015 Mar 20;4(1):204-47.
Vargas-Mendoza N., Madrigal-Santillán E., Morales-González A., Esquivel-Soto J., Esquivel-Chirino C., García-Luna Y., González-Rubio M., Gayosso-de-Lucio J.A., Morales-González J.A. “Hepatoprotective effect of silymarin.” World J. Hepatol. 2014;6:144–149.
Zholobenko A, Modriansky M. “Silymarin and its constituents in cardiac preconditioning.” Fitoterapia. 2014 Sep;97:122-32.
Vostalova J, Vidlar A, Ulrichova J, Vrbkova J, Simanek V, Student V. “Use of selenium-silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men.” Phytomedicine. 2013 Dec 15;21(1):75-81.
Moayedi B, Gharagozloo M, Esmaeil N, Maracy MR, Hoorfar H, Jalaeikar M. “A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.” European Journal of Haematology. 2013 Mar;90(3):202-9.
Féher J, Lengyel G. “Silymarin in the prevention and treatment of liver diseases and primary liver cancer.” Current Pharmaceutical Biotechnology. 2012 Jan;13(1):210-7.
Bakhshaee M, Jabbari F, Hoseini S, Farid R, Sadeghian MH, Rajati M, Mohamadpoor AH, Movahhed R, Zamani MA. “Effect of silymarin in the treatment of allergic rhinitis.” Journal of Otolaryngology - Head & Neck Surgery. 2011 Dec;145(6):904-9.
Roozbeh J, Shahriyari B, Akmali M, Vessal G, Pakfetrat M, Raees Jalali GA, Afshariani R, Hasheminasab M, Ghahramani N. “Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis.” Renal Failure. Nov, 2011;33(2):118-23.
Matveev AV, Koniaeva EI, Kurchenko VP, Shchekatikhina AS. “Hepatoprotective properties of silymarin.” Eksp Klin Gastroenterol. 2011;(2):130-5.
Abenavoli L, Capasso R, Milic N, Capasso F. “Milk thistle in liver diseases: past, present, future.” Phytotherapy Research. 2010 Oct;24(10):1423-32.
Vidlar A, Vostalova J, Ulrichova J, Student V, Krajicek M, Vrbkova J, Simanek V. “The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy - a six month placebo-controlled double-blind clinical trial.” Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Sep;154(3):239-44.
El-Kamary SS, Shardell MD, Abdel-Hamid M, Ismail S, El-Ateek M, Metwally M, Mikhail N, Hashem M, Mousa A, Aboul-Fotouh A, El-Kassas M, Esmat G, Strickland GT. “A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.” Phytomedicine. 2009 May;16(5):391-400.
Hussain SA, Jassim NA, Numan IT, Al-Khalifa II, Abdullah TA. “Anti-inflammatory activity of silymarin in patients with knee osteoarthritis. A comparative study with piroxicam and meloxicam.” Saudi Medical Journal. 2009 Jan;30(1):98-103.
Fehér J, Lengyel G. “Silymarin in the treatment of chronic liver diseases: past and future.” Orvosi Hetilap Journal. 2008 Dec 21;149 (51):2413-8.
Angulo P, Jorgensen RA, Kowdley KV, Lindor KD. “Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study.” Digestive Diseases and Sciences. 2008 Jun; 53(6):1716-20.
Saller, R., Brignoli, R., Melzer, J., Meier R. “An updated systematic review with meta-analysis for the clinical evidence of silymarin.” Forsch. Komplementärmed., 2008, Feb 15 , 9–20.
Pradhan SC, Girish C. “Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.” Indian Journal of Medical Research. 2006 Nov;124(5):491-504.
Műzes Gy., Deák Gy., Láng I. “Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)” Orv. Hetil., 1990 Apr 22, 131 , 863–866.
Ferenci, P., Dragosics, B., Dittrich, H. “Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.” J. Hepatol., 1989, July 9, 105–113.
Richie JP Jr, Das A, Calcagnotto AM, Sinha R, Neidig W, Liao J, Lengerich EJ, Berg A, Hartman TJ, Ciccarella A, Baker A, Kaag MG, Goodin S, DiPaola RS, El-Bayoumy K. “Comparative Effects of Two Different Forms of Selenium on Oxidative Stress Biomarkers in Healthy Men: A Randomized Clinical Trial” Cancer Prev Res August 1, 2014 7:796-804
Waters DJ, Shen S, Kengeri SS, et al. “Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.” Nutrients 2012; 4(11):1650-63. doi: 10.3390/nu4111650.
Algotar, A. M., Stratton, M. S., Ahmann, Frederick. R., Ranger-Moore, J., Nagle, R. B., Thompson, P. A., Slate, E., Hsu, C. H., Dalkin, B. L., Sindhwani, P., Holmes, M. A., Tuckey, J. A., Graham, David. L., Parnes, H. L., Clark, L. C. and Stratton, S. P. (2013), “Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.” Prostate, 73: 328–335.
Li, Zeqin Dong, Chunying Chen, Bai Li, Yuxi Gao, Liya Qu, Tianchen Wang, Xin Fu, Yuliang Zhao, and Zhifang Chai “Organic Selenium Supplementation Increases Mercury Excretion and Decreases Oxidative Damage in Long-Term Mercury-Exposed Residents from Wanshan, China” Environmental Science & Technology 2012 46 (20), 11313-11318
Facompre,N, El-Bayoumy K. “Potential Stages for Prostate Cancer Prevention with Selenium: Implications for Cancer Survivors.” Cancer Research. April 1, 2009 69; 2699.
El-Bayoumy K, Sinha R. “Molecular chemoprevention by selenium: a genomic approach.” Mutation Research. 2005; 591(1-2):224-36.
Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. “Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.” British Journal of Urology International. 2003;91(7):608-12.
El-Bayoumy K, Richie JP Jr, Boyiri T, Komninou D, Prokopczyk B, Trushin N, Kleinman W, Cox J, Pittman B, Colosimo S. “Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study.” Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1459-65.
Clark LC, Dalkin B, Krongrad A, Combs GF Hr,, Turnbull BW, Slate EH, Witherington R, Herlong J, Janosko E, Carpenter D, Borosso C, Falk S, Rounder J. “Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.” British Journal of Urology International. May, 1998. Volume 81, Issue 5, pages 730–734.
Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR. “Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.” The Journal of the American Medical Association. 1996 Dec 25;276(24):1957-63.
Park K, Rimm EB, Siscovick DS, Spiegelman D, Manson JE, Morris JS, Hu FB, Mozaffarian D. “Toenail selenium and incidence of type 2 diabetes in U.S. men and women.” Diabetes Care. 2012 Jul;35(7):1544-51.
Petrovski BÉ, Pataki V, Jenei T, Adány R, Vokó Z. “Selenium levels in men with liver disease in Hungary.” Journal of Trace Elements in Medicine and Biology. 2012 Jan;26(1):31-5.
Himoto T, Yoneyama H, Kurokohchi K, Inukai M, Masugata H, Goda F, Haba R, Watababe S, Kubota S, Senda S, Masaki T. “Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease.” Nutrition Research. 2011 Nov;31(11):829-35.
Yu SY, Zhu YJ, Li WG. “Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong.” Biological Trace Element Research. 1997 Jan;56(1):117-24.
Kuyumcu A, Akyol A, Buyuktuncer Z, Ozmen MM, Besler HT “Improved oxidative status in major abdominal surgery patients after N-acetyl cysteine supplementation.” Nutrition Journal 2015 Jan 6;14:4.
Conrad C, Lymp J, Thompson V, Dunn C, Davies Z, Chatfield B, Nichols D, Clancy J, Vender R, Egan ME, Quittell L, Michelson P, Antony V, Spahr J, Rubenstein RC, Moss RB, Herzenberg LA, Goss CH2, Tirouvanziam R. “Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.” Journal of Cystic Fibrosis. 2015 Mar;14(2):219-27.
Ozdemir ZC, Koc A, Aycicek A, Kocyigit A. “N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.” Hemoglobin. 2014; 38(5):359-64.
Carlsten C, MacNutt MJ, Zhang Z, Sava F, Pui MM. “Anti-oxidant N-acetylcysteine diminishes diesel exhaust-induced increased airway responsiveness in person with airway hyper-reactivity.” Toxicology Science 2014 Jun;139(2):479-87.
Kasperczyk S, Dobrakowski M, Kasperczyk A, Ostałowska A, Birkner E. “The administration of N-acetylcysteine reduces oxidative stress and regulates glutathione metabolism in the blood cells of workers exposed to lead.” Clinical Toxicology. 2013 Jul;51(6):480-6.
Heard K, Green J. “Acetylcysteine therapy for acetaminophen poisoning.” Current Pharmaceutical Biotechnology. 2012 Aug;13(10):1917-23.
Cobley JN, McGlory C, Morton JP, Close GL. “N-Acetylcysteine Attenuates Fatigue Following Repeated-Bouts of Intermittent Exercise: Practical Implications for Tournament Situations.” International Journal of Sport Nutrition and Exercise Metabolism. Epub 2011 Aug 29.
De Benedetto F, Aceto A, Dragani B, Spacone A, Formisano S, Pela R, Donner CF, Sanguinetti CM. “Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD.” Pulmonary Pharmacology & Therapeutics. 2005 Dec;18(1):41-7.
*The views and opinions expressed by contributors and or product reviews are their own and not
necessarily those of NatureCity. These reviews should not be taken as recommendations but rather
client opinions of the products that they have used.